Skip to main content
Top
Published in: Abdominal Radiology 3/2020

01-03-2020 | Obesity | Hepatobiliary

Accuracy of common proton density fat fraction thresholds for magnitude- and complex-based chemical shift-encoded MRI for assessing hepatic steatosis in patients with obesity

Authors: Guilherme Moura Cunha, Tydus T. Thai, Gavin Hamilton, Yesenia Covarrubias, Alexandra Schlein, Michael S. Middleton, Curtis N. Wiens, Alan McMillan, Rashmi Agni, Luke M. Funk, Guilherme M. Campos, Santiago Horgan, Garth Jacobson, Tanya Wolfson, Anthony Gamst, Jeffrey B. Schwimmer, Scott B. Reeder, Claude B. Sirlin

Published in: Abdominal Radiology | Issue 3/2020

Login to get access

Abstract

Purpose

MRI proton density fat fraction (PDFF) can be calculated using magnitude (MRI-M) or complex (MRI-C) MRI data. The purpose of this study was to identify, assess, and compare the accuracy of common PDFF thresholds for MRI-M and MRI-C for assessing hepatic steatosis in patients with obesity, using histology as reference.

Methods

This two-center prospective study included patients undergoing MRI-C- and MRI-M-PDFF estimations within 3 days before weight loss surgery. Liver biopsy was performed, and histology-determined steatosis grades were used as reference standard. Using receiver operating characteristics (ROC) analysis on data pooled from both methods, single common thresholds for diagnosing and differentiating none or mild (0–1) from moderate to severe steatosis (2–3) were selected as the ones achieving the highest sensitivity while providing at least 90% specificity. Selection methods were cross-validated. Performances were compared using McNemar’s tests.

Results

Of 81 included patients, 54 (67%) had steatosis. The common PDFF threshold for diagnosing steatosis was 5.4%, which provided a cross-validated 0.88 (95% CI 0.77–0.95) sensitivity and 0.92 (0.75–0.99) specificity for MRI-M and 0.87 sensitivity (0.75–0.94) with 0.81 (0.61–0.93) specificity for MRI-C. The common PDFF threshold to differentiate steatosis grades 0–1 from 2 to 3 was 14.7%, which provided cross-validated 0.86 (95% CI 0.59–0.98) sensitivity and 0.95 (0.87–0.99) specificity for MRI-M and 0.93 sensitivity (0.68–0.99) with 0.97(0.89–0.99) specificity for MRI-C.

Conclusion

If independently validated, diagnostic thresholds of 5.4% and 14.7% could be adopted for both techniques for detecting and differentiating none to mild from moderate to severe steatosis, respectively, with high diagnostic accuracy.
Literature
1.
go back to reference Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, George J, Bugianesi E. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nature reviews Gastroenterology & hepatology. 2018 Jan;15(1):11CrossRef Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, George J, Bugianesi E. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nature reviews Gastroenterology & hepatology. 2018 Jan;15(1):11CrossRef
2.
go back to reference Yokoo T, Serai SD, Pirasteh A, Bashir MR, Hamilton G, Hernando D, Hu HH, Hetterich H, Kühn JP, Kukuk GM, Loomba R. Linearity, bias, and precision of hepatic proton density fat fraction measurements by using MR imaging: a meta-analysis. Radiology. 2017 Sep 11;286(2):486-98.PubMedPubMedCentralCrossRef Yokoo T, Serai SD, Pirasteh A, Bashir MR, Hamilton G, Hernando D, Hu HH, Hetterich H, Kühn JP, Kukuk GM, Loomba R. Linearity, bias, and precision of hepatic proton density fat fraction measurements by using MR imaging: a meta-analysis. Radiology. 2017 Sep 11;286(2):486-98.PubMedPubMedCentralCrossRef
3.
go back to reference [Withheld during submission for blinding purposes]. [Withheld during submission for blinding purposes].
4.
go back to reference Bydder M, Yokoo T, Hamilton G, Middleton MS, Chavez AD, Schwimmer JB, Lavine JE, Sirlin CB. Relaxation effects in the quantification of fat using gradient echo imaging. Magnetic resonance imaging. 2008 Apr 1;26(3):347-59PubMedPubMedCentralCrossRef Bydder M, Yokoo T, Hamilton G, Middleton MS, Chavez AD, Schwimmer JB, Lavine JE, Sirlin CB. Relaxation effects in the quantification of fat using gradient echo imaging. Magnetic resonance imaging. 2008 Apr 1;26(3):347-59PubMedPubMedCentralCrossRef
5.
go back to reference Liu CY, McKenzie CA, Yu H, Brittain JH, Reeder SB. Fat quantification with IDEAL gradient echo imaging: correction of bias from T1 and noise. Magnetic Resonance in Medicine: An Official Journal of the International Society for Magnetic Resonance in Medicine. 2007 Aug;58(2):354-64.CrossRef Liu CY, McKenzie CA, Yu H, Brittain JH, Reeder SB. Fat quantification with IDEAL gradient echo imaging: correction of bias from T1 and noise. Magnetic Resonance in Medicine: An Official Journal of the International Society for Magnetic Resonance in Medicine. 2007 Aug;58(2):354-64.CrossRef
6.
go back to reference Yu H, McKenzie CA, Shimakawa A, Vu AT, Brau AC, Beatty PJ, Pineda AR, Brittain JH, Reeder SB. Multiecho reconstruction for simultaneous water-fat decomposition and T2* estimation. Journal of Magnetic Resonance Imaging: An Official Journal of the International Society for Magnetic Resonance in Medicine. 2007 Oct;26(4):1153-61.CrossRef Yu H, McKenzie CA, Shimakawa A, Vu AT, Brau AC, Beatty PJ, Pineda AR, Brittain JH, Reeder SB. Multiecho reconstruction for simultaneous water-fat decomposition and T2* estimation. Journal of Magnetic Resonance Imaging: An Official Journal of the International Society for Magnetic Resonance in Medicine. 2007 Oct;26(4):1153-61.CrossRef
7.
go back to reference Yu H, Shimakawa A, McKenzie CA, Brodsky E, Brittain JH, Reeder SB. Multiecho water-fat separation and simultaneous R estimation with multifrequency fat spectrum modeling. Magnetic Resonance in Medicine: An Official Journal of the International Society for Magnetic Resonance in Medicine. 2008 Nov;60(5):1122-34.CrossRef Yu H, Shimakawa A, McKenzie CA, Brodsky E, Brittain JH, Reeder SB. Multiecho water-fat separation and simultaneous R estimation with multifrequency fat spectrum modeling. Magnetic Resonance in Medicine: An Official Journal of the International Society for Magnetic Resonance in Medicine. 2008 Nov;60(5):1122-34.CrossRef
8.
go back to reference Haufe WM, Wolfson T, Hooker CA, Hooker JC, Covarrubias Y, Schlein AN, Hamilton G, Middleton MS, Angeles JE, Hernando D, Reeder SB. Accuracy of PDFF estimation by magnitude‐based and complex‐based MRI in children with MR spectroscopy as a reference. Journal of Magnetic Resonance Imaging. 2017 Dec;46(6):1641-7.PubMedCrossRef Haufe WM, Wolfson T, Hooker CA, Hooker JC, Covarrubias Y, Schlein AN, Hamilton G, Middleton MS, Angeles JE, Hernando D, Reeder SB. Accuracy of PDFF estimation by magnitude‐based and complex‐based MRI in children with MR spectroscopy as a reference. Journal of Magnetic Resonance Imaging. 2017 Dec;46(6):1641-7.PubMedCrossRef
9.
go back to reference Yu H, Shimakawa A, Hines CD, McKenzie CA, Hamilton G, Sirlin CB, Brittain JH, Reeder SB. Combination of complex‐based and magnitude‐based multiecho water‐fat separation for accurate quantification of fat‐fraction. Magnetic resonance in medicine. 2011 Jul;66(1):199-206.PubMedPubMedCentralCrossRef Yu H, Shimakawa A, Hines CD, McKenzie CA, Hamilton G, Sirlin CB, Brittain JH, Reeder SB. Combination of complex‐based and magnitude‐based multiecho water‐fat separation for accurate quantification of fat‐fraction. Magnetic resonance in medicine. 2011 Jul;66(1):199-206.PubMedPubMedCentralCrossRef
10.
go back to reference Hernando D, Hines CD, Yu H, Reeder SB. Addressing phase errors in fat‐water imaging using a mixed magnitude/complex fitting method. Magnetic resonance in medicine. 2012 Mar;67(3):638-44.PubMedCrossRef Hernando D, Hines CD, Yu H, Reeder SB. Addressing phase errors in fat‐water imaging using a mixed magnitude/complex fitting method. Magnetic resonance in medicine. 2012 Mar;67(3):638-44.PubMedCrossRef
11.
go back to reference Tang A, Tan J, Sun M, Hamilton G, Bydder M, Wolfson T, Gamst AC, Middleton M, Brunt EM, Loomba R, Lavine JE. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology. 2013 May;267(2):422-31PubMedPubMedCentralCrossRef Tang A, Tan J, Sun M, Hamilton G, Bydder M, Wolfson T, Gamst AC, Middleton M, Brunt EM, Loomba R, Lavine JE. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology. 2013 May;267(2):422-31PubMedPubMedCentralCrossRef
12.
go back to reference Tang A, Desai A, Hamilton G, Wolfson T, Gamst A, Lam J, Clark L, Hooker J, Chavez T, Ang BD, Middleton MS. Accuracy of MR imaging–estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology. 2014 Sep 22;274(2):416-25PubMedPubMedCentralCrossRef Tang A, Desai A, Hamilton G, Wolfson T, Gamst A, Lam J, Clark L, Hooker J, Chavez T, Ang BD, Middleton MS. Accuracy of MR imaging–estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology. 2014 Sep 22;274(2):416-25PubMedPubMedCentralCrossRef
13.
go back to reference Heba ER, Desai A, Zand KA, Hamilton G, Wolfson T, Schlein AN, Gamst A, Loomba R, Sirlin CB, Middleton MS. Accuracy and the effect of possible subject-based confounders of magnitude-based MRI for estimating hepatic proton density fat fraction in adults, using MR spectroscopy as reference. Journal of Magnetic Resonance Imaging. 2016 Feb;43(2):398-406.PubMedCrossRef Heba ER, Desai A, Zand KA, Hamilton G, Wolfson T, Schlein AN, Gamst A, Loomba R, Sirlin CB, Middleton MS. Accuracy and the effect of possible subject-based confounders of magnitude-based MRI for estimating hepatic proton density fat fraction in adults, using MR spectroscopy as reference. Journal of Magnetic Resonance Imaging. 2016 Feb;43(2):398-406.PubMedCrossRef
14.
go back to reference Zand KA, Shah A, Heba E, Wolfson T, Hamilton G, Lam J, Chen J, Hooker JC, Gamst AC, Middleton MS, Schwimmer JB. Accuracy of multiecho magnitude-based MRI (M-MRI) for estimation of hepatic proton density fat fraction (PDFF) in children. Journal of Magnetic Resonance Imaging. 2015 Nov;42(5):1223-32.PubMedCrossRef Zand KA, Shah A, Heba E, Wolfson T, Hamilton G, Lam J, Chen J, Hooker JC, Gamst AC, Middleton MS, Schwimmer JB. Accuracy of multiecho magnitude-based MRI (M-MRI) for estimation of hepatic proton density fat fraction (PDFF) in children. Journal of Magnetic Resonance Imaging. 2015 Nov;42(5):1223-32.PubMedCrossRef
15.
go back to reference Joshi M, Dillman JR, Singh K, Serai SD, Towbin AJ, Xanthakos S, Zhang B, Su W, Trout AT. Quantitative MRI of fatty liver disease in a large pediatric cohort: correlation between liver fat fraction, stiffness, volume, and patient-specific factors. Abdominal Radiology. 2018 May 1;43(5):1168-79.PubMedCrossRef Joshi M, Dillman JR, Singh K, Serai SD, Towbin AJ, Xanthakos S, Zhang B, Su W, Trout AT. Quantitative MRI of fatty liver disease in a large pediatric cohort: correlation between liver fat fraction, stiffness, volume, and patient-specific factors. Abdominal Radiology. 2018 May 1;43(5):1168-79.PubMedCrossRef
16.
go back to reference Armstrong T, Ly KV, Murthy S, Ghahremani S, Kim GH, Calkins KL, Wu HH. Free-breathing quantification of hepatic fat in healthy children and children with nonalcoholic fatty liver disease using a multi-echo 3-D stack-of-radial MRI technique. Pediatric radiology. 2018 May 4:1-3. Armstrong T, Ly KV, Murthy S, Ghahremani S, Kim GH, Calkins KL, Wu HH. Free-breathing quantification of hepatic fat in healthy children and children with nonalcoholic fatty liver disease using a multi-echo 3-D stack-of-radial MRI technique. Pediatric radiology. 2018 May 4:1-3.
17.
go back to reference Middleton MS, Heba ER, Hooker CA, Bashir MR, Fowler KJ, Sandrasegaran K, Brunt EM, Kleiner DE, Doo E, Van Natta ML, Lavine JE. Agreement between magnetic resonance imaging proton density fat fraction measurements and pathologist-assigned steatosis grades of liver biopsies from adults with nonalcoholic steatohepatitis. Gastroenterology. 2017 Sep 1;153(3):753-61.PubMedPubMedCentralCrossRef Middleton MS, Heba ER, Hooker CA, Bashir MR, Fowler KJ, Sandrasegaran K, Brunt EM, Kleiner DE, Doo E, Van Natta ML, Lavine JE. Agreement between magnetic resonance imaging proton density fat fraction measurements and pathologist-assigned steatosis grades of liver biopsies from adults with nonalcoholic steatohepatitis. Gastroenterology. 2017 Sep 1;153(3):753-61.PubMedPubMedCentralCrossRef
18.
go back to reference França M, Alberich-Bayarri A, Martí-Bonmatí L, Oliveira P, Costa FE, Porto G, Vizcaíno JR, Gonzalez JS, Ribeiro E, Oliveira J, Miranda HP. Accurate simultaneous quantification of liver steatosis and iron overload in diffuse liver diseases with MRI. Abdominal Radiology. 2017 May 1;42(5):1434-43PubMedCrossRef França M, Alberich-Bayarri A, Martí-Bonmatí L, Oliveira P, Costa FE, Porto G, Vizcaíno JR, Gonzalez JS, Ribeiro E, Oliveira J, Miranda HP. Accurate simultaneous quantification of liver steatosis and iron overload in diffuse liver diseases with MRI. Abdominal Radiology. 2017 May 1;42(5):1434-43PubMedCrossRef
19.
go back to reference Reeder, Scott B., Houchun H. Hu, and Claude B. Sirlin. “Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration.” Journal of magnetic resonance imaging 36.5 (2012): 1011-1014.PubMedCrossRef Reeder, Scott B., Houchun H. Hu, and Claude B. Sirlin. “Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration.” Journal of magnetic resonance imaging 36.5 (2012): 1011-1014.PubMedCrossRef
20.
go back to reference Artz NS, Haufe WM, Hooker CA, Hamilton G, Wolfson T, Campos GM, Gamst AC, Schwimmer JB, Sirlin CB, Reeder SB. Reproducibility of MR-based liver fat quantification across field strength: Same-day comparison between 1.5 T and 3T in obese subjects. Journal of Magnetic Resonance Imaging. 2015 Sep;42(3):811-7PubMedCrossRef Artz NS, Haufe WM, Hooker CA, Hamilton G, Wolfson T, Campos GM, Gamst AC, Schwimmer JB, Sirlin CB, Reeder SB. Reproducibility of MR-based liver fat quantification across field strength: Same-day comparison between 1.5 T and 3T in obese subjects. Journal of Magnetic Resonance Imaging. 2015 Sep;42(3):811-7PubMedCrossRef
21.
go back to reference Kang BK, Yu ES, Lee SS, Lee Y, Kim N, Sirlin CB, Cho EY, Yeom SK, Byun JH, Park SH, Lee MG. Hepatic fat quantification: a prospective comparison of magnetic resonance spectroscopy and analysis methods for chemical-shift gradient echo magnetic resonance imaging with histologic assessment as the reference standard. Investigative radiology. 2012 Jun 1;47(6):368-75.PubMedCrossRef Kang BK, Yu ES, Lee SS, Lee Y, Kim N, Sirlin CB, Cho EY, Yeom SK, Byun JH, Park SH, Lee MG. Hepatic fat quantification: a prospective comparison of magnetic resonance spectroscopy and analysis methods for chemical-shift gradient echo magnetic resonance imaging with histologic assessment as the reference standard. Investigative radiology. 2012 Jun 1;47(6):368-75.PubMedCrossRef
22.
go back to reference Idilman IS, Aniktar H, Idilman R, Kabacam G, Savas B, Elhan A, Celik A, Bahar K, Karcaaltincaba M. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology. 2013 Jun;267(3):767-75.PubMedCrossRef Idilman IS, Aniktar H, Idilman R, Kabacam G, Savas B, Elhan A, Celik A, Bahar K, Karcaaltincaba M. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology. 2013 Jun;267(3):767-75.PubMedCrossRef
23.
go back to reference Kühn JP, Hernando D, Muñoz del Rio A, et al. Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results. Radiology. 2012;265(1):133–142PubMedPubMedCentralCrossRef Kühn JP, Hernando D, Muñoz del Rio A, et al. Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results. Radiology. 2012;265(1):133–142PubMedPubMedCentralCrossRef
24.
go back to reference Imajo K, Kessoku T, Honda Y, Tomeno W, Ogawa Y, Mawatari H, Fujita K, Yoneda M, Taguri M, Hyogo H, Sumida Y. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology. 2016 Mar 1;150(3):626-37PubMedCrossRef Imajo K, Kessoku T, Honda Y, Tomeno W, Ogawa Y, Mawatari H, Fujita K, Yoneda M, Taguri M, Hyogo H, Sumida Y. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology. 2016 Mar 1;150(3):626-37PubMedCrossRef
26.
go back to reference Mangus RS, Kubal CA, Fridell JA, Pena JM, Frost EM, Joseph Tector A. Alcohol abuse in deceased liver donors: impact on post-transplant outcomes. Liver International. 2015 Jan;35(1):171-5.PubMedCrossRef Mangus RS, Kubal CA, Fridell JA, Pena JM, Frost EM, Joseph Tector A. Alcohol abuse in deceased liver donors: impact on post-transplant outcomes. Liver International. 2015 Jan;35(1):171-5.PubMedCrossRef
27.
go back to reference Kleiner DE, Brunt EM, Natta MV, et al. Design and Validation of a Histological Scoring System for Nonalcoholic Fatty Liver Disease. Hepatology. 2005;41(6):1313–21PubMedCrossRef Kleiner DE, Brunt EM, Natta MV, et al. Design and Validation of a Histological Scoring System for Nonalcoholic Fatty Liver Disease. Hepatology. 2005;41(6):1313–21PubMedCrossRef
28.
go back to reference Kang GH, Cruite I, Shiehmorteza M, Wolfson T, Gamst AC, Hamilton G, Bydder M, Middleton MS, Sirlin CB. Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms. Journal of magnetic resonance imaging. 2011 Oct 1;34(4):928-34.PubMedCrossRef Kang GH, Cruite I, Shiehmorteza M, Wolfson T, Gamst AC, Hamilton G, Bydder M, Middleton MS, Sirlin CB. Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms. Journal of magnetic resonance imaging. 2011 Oct 1;34(4):928-34.PubMedCrossRef
29.
go back to reference Lazo M, Hernaez R, Eberhardt MS, Bonekamp S, Kamel I, Guallar E, Koteish A, Brancati FL, Clark JM. Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988–1994. American journal of epidemiology. 2013 May 23;178(1):38-45.PubMedPubMedCentralCrossRef Lazo M, Hernaez R, Eberhardt MS, Bonekamp S, Kamel I, Guallar E, Koteish A, Brancati FL, Clark JM. Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988–1994. American journal of epidemiology. 2013 May 23;178(1):38-45.PubMedPubMedCentralCrossRef
30.
go back to reference Qureshi K, Abrams GA. Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome. Clinical obesity. 2016 Apr;6(2):117-23.PubMedCrossRef Qureshi K, Abrams GA. Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome. Clinical obesity. 2016 Apr;6(2):117-23.PubMedCrossRef
31.
go back to reference Permutt Z, Le TA, Peterson MR, Seki E, Brenner DA, Sirlin C, Loomba R. Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease–MRI accurately quantifies hepatic steatosis in NAFLD. Alimentary pharmacology & therapeutics. 2012 Jul 1;36(1):22-9.CrossRef Permutt Z, Le TA, Peterson MR, Seki E, Brenner DA, Sirlin C, Loomba R. Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease–MRI accurately quantifies hepatic steatosis in NAFLD. Alimentary pharmacology & therapeutics. 2012 Jul 1;36(1):22-9.CrossRef
32.
go back to reference Chalasani N, Wilson L, Kleiner DE, Cummings OW, Brunt EM, Ünalp A, NASH Clinical Research Network. Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease. Journal of hepatology. 2008 May 1;48(5):829-34. Chalasani N, Wilson L, Kleiner DE, Cummings OW, Brunt EM, Ünalp A, NASH Clinical Research Network. Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease. Journal of hepatology. 2008 May 1;48(5):829-34.
33.
go back to reference de Graaf EL, Kench J, Dilworth P, Shackel NA, Strasser SI, Joseph D, Pleass H, Crawford M, McCaughan GW, Verran DJ. Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index. Journal of gastroenterology and hepatology. 2012 Mar;27(3):540-6.PubMedCrossRef de Graaf EL, Kench J, Dilworth P, Shackel NA, Strasser SI, Joseph D, Pleass H, Crawford M, McCaughan GW, Verran DJ. Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index. Journal of gastroenterology and hepatology. 2012 Mar;27(3):540-6.PubMedCrossRef
34.
go back to reference Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S, Hobbs HH, Dobbins RL. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. American Journal of Physiology-Endocrinology and Metabolism. 2005 Feb;288(2):E462-8PubMedCrossRef Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S, Hobbs HH, Dobbins RL. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. American Journal of Physiology-Endocrinology and Metabolism. 2005 Feb;288(2):E462-8PubMedCrossRef
35.
go back to reference Hernando D, Liang ZP, Kellman P. Chemical shift–based water/fat separation: a comparison of signal models. Magnetic resonance in medicine. 2010 Sep;64(3):811-22.PubMedPubMedCentralCrossRef Hernando D, Liang ZP, Kellman P. Chemical shift–based water/fat separation: a comparison of signal models. Magnetic resonance in medicine. 2010 Sep;64(3):811-22.PubMedPubMedCentralCrossRef
36.
go back to reference Horng, Debra E., et al. “Comparison of R2* correction methods for accurate fat quantification in fatty liver.” Journal of Magnetic Resonance Imaging 37.2 (2013): 414-422.PubMedCrossRef Horng, Debra E., et al. “Comparison of R2* correction methods for accurate fat quantification in fatty liver.” Journal of Magnetic Resonance Imaging 37.2 (2013): 414-422.PubMedCrossRef
37.
go back to reference Nasr P, Forsgren MF, Ignatova S, Dahlström N, Cedersund G, Leinhard OD, Norén B, Ekstedt M, Lundberg P, Kechagias S. Using a 3% proton density fat fraction as a cut-off value increases sensitivity of detection of hepatic steatosis, based on results from histopathology analysis. Gastroenterology. 2017 Jul 1;153(1):53-5.PubMedCrossRef Nasr P, Forsgren MF, Ignatova S, Dahlström N, Cedersund G, Leinhard OD, Norén B, Ekstedt M, Lundberg P, Kechagias S. Using a 3% proton density fat fraction as a cut-off value increases sensitivity of detection of hepatic steatosis, based on results from histopathology analysis. Gastroenterology. 2017 Jul 1;153(1):53-5.PubMedCrossRef
38.
go back to reference Schwimmer JB, Middleton MS, Behling C, Newton KP, Awai HI, Paiz MN, Lam J, Hooker JC, Hamilton G, Fontanesi J, Sirlin CB. Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease. Hepatology. 2015 Jun 1;61(6):1887-95PubMedPubMedCentralCrossRef Schwimmer JB, Middleton MS, Behling C, Newton KP, Awai HI, Paiz MN, Lam J, Hooker JC, Hamilton G, Fontanesi J, Sirlin CB. Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease. Hepatology. 2015 Jun 1;61(6):1887-95PubMedPubMedCentralCrossRef
Metadata
Title
Accuracy of common proton density fat fraction thresholds for magnitude- and complex-based chemical shift-encoded MRI for assessing hepatic steatosis in patients with obesity
Authors
Guilherme Moura Cunha
Tydus T. Thai
Gavin Hamilton
Yesenia Covarrubias
Alexandra Schlein
Michael S. Middleton
Curtis N. Wiens
Alan McMillan
Rashmi Agni
Luke M. Funk
Guilherme M. Campos
Santiago Horgan
Garth Jacobson
Tanya Wolfson
Anthony Gamst
Jeffrey B. Schwimmer
Scott B. Reeder
Claude B. Sirlin
Publication date
01-03-2020
Publisher
Springer US
Published in
Abdominal Radiology / Issue 3/2020
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-019-02350-3

Other articles of this Issue 3/2020

Abdominal Radiology 3/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.